Skip to content

BELPHARMA

Active
Public limited companyfounded 1992active for 34 yearsAvenue Joseph Abras(BL) 54, 5001 Namur, BelgiumKBO/BCE: BE 0447.683.110
Summary

BELPHARMA has been active since 1992 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €425,779 and a net result of €62,368. Equity is growing by about 9.9% per year across the filed financial years. Its solvency ranks better than 84% of 4,961 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Register details

Identification
Legal formPublic limited company
Founded25-06-1992
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0447683110
Also 9925:BE0447683110
Registered 12-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 18 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Namurunit no. 2.058.285.758
1 permission
Apotheek (LM>3 maand) · since 01-01-2006

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 1992
registered office establishment The establishment unit on the map
Ground area
1,417 m²
Building footprint
61 m²
Building volume
490 m³
Parcel 92010C0093/00F002, Wallonia · tallest building 10.4 m. Linked by address, not a title deed.
1 establishment unit
Avenue Joseph Abras(BL) 54, 5001 Namur
Retail sale of pharmaceutical products
since 1992unit no. 2.058.285.758
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
92010C0093/00F002 Wallonia 1,417 m² 1 · 61 m² 10.4 m · 3
How the parcels are linked
Good to know
The parcel matches the address exactly.